Trial Profile
The efficacy of dulaglutide in diabetic patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2017
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Dec 2015 New trial record